This article explores how GLP-1 medications affect metabolism, who may benefit from treatment, and important safety considerations for UK patients
Mistake 5: self-adjusting frequency without provider guidance Reducing from daily to every other day because you "feel fine" or increasing to twice daily because you want faster results
It can be observed that among the suicidal and self-injurious reports related to GLP-1RA, 199 cases were associated with liraglutide, 134 cases with exenatide, 106 cases with semaglutide, 89 cases with dulaglutide, 3 cases with albiglutide, and 3 cases with lixisenatide
Can I pre-load syringes with GHK-Cu for later use
Read the full consensus here: AJCN Nutritional Priorities to Support GLP-1 Therapy Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society ajcn.nutrition.org To view or add a comment, sign in More from this author Explore content categories